EGFR and cancer: Parts of the work were previously presented at the German Pharm-Tox Summit (Göttingen, 2017): Hafner S, Lang S, Syrovets T, Simmet T: Anti-Cancer Efficacy of the Cardenolide Glycoside Acovenoside A is Mediated by EGFR Arrest.